Ranolazine
Ranexa, Latixa (ranolazine) is a small molecule pharmaceutical. Ranolazine was first approved as Ranexa on 2006-01-27. It is used to treat angina pectoris in the USA. It has been approved in Europe to treat angina pectoris.
Trade Name | Latixa, Ranexa |
---|---|
Common Name | Ranolazine |
Indication | angina pectoris |
Drug Class | Antiarrhythmic/antianginal/antihypertensive agents, phthalazine like structure |